Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. SPIRONOLACTONE MICROFINE RATIOPHARM (spironolactone)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

SPIRONOLACTONE MICROFINE RATIOPHARM (spironolactone)

Medicine - Posted on Jul 30 2010 - Updated on Jun 12 2019
Active substance (DCI)
  • spironolactone
history (3)
  • 7/21/10

    SPIRONOLACTONE MICROFINE RATIOPHARM (spironolactone)

    SPIRONOLACTONE MICROFINE RATIOPHARM (spironolactone)
    icône flèche
  • 9/26/07

    SPIRONOLACTONE Microfine (spironolactone)

    SPIRONOLACTONE Microfine (spironolactone)
    icône flèche
  • 9/18/02

    SPIRONOLACTONE MICROFINE RATIOPHARM 50mg, comprimés sécables (boîte de 30)

    SPIRONOLACTONE MICROFINE RATIOPHARM 50mg, comprimés sécables (boîte de 30)
    icône flèche
Technical information
ATC code
  • C03DA01
Manufacturer
Laboratoire RATIOPHARM
Presentation

SPIRONOLACTONE MICROFINE RATIOPHARM 50 mg, comprimé sécable

  • Boîte de 90 - Code CIP : 3722260
  • Boîte de 30 - Code CIP : 3506065
All our publications
    Autoimmune diseases Drug therapy Endocrine system diseases Hypertension Neuromuscular diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
pXyxPAt06Lmn6fPe